Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bispecific antibodies
bispecific antibodies
Deaths spur partial hold for Xencor’s CD3 bispecific for leukemia, partnered with Novartis in $2.5B deal
Endpoints
Wed, 02/20/19 - 10:00 am
Xencor
XmAb14045
bispecific antibodies
acute myeloid leukemia
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Tue, 02/5/19 - 10:05 am
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies
In R&D rethink, Novartis ditches part of $2.6B Xencor bispecific pact
Fierce Biotech
Tue, 01/8/19 - 10:31 am
Novartis
Xencor
bispecific antibodies
FDA slaps partial hold on MacroGenics for bispecific cancer trials as liver tox spurs safety fears
Endpoints
Mon, 12/10/18 - 09:52 am
Macrogenics
FDA
bispecific antibodies
clinical trials
B7-H3 × CD3
BeiGene bags Asian rights to Zymeworks’ HER2 bispecifics
Fierce Biotech
Tue, 11/27/18 - 11:32 pm
BeiGene
Zymeworks
bispecific antibodies
ZW25
ZW49
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Tue, 10/2/18 - 12:02 pm
Roche
Go Therapeutics
drug development
bispecific antibodies
Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies
Med City News
Thu, 06/7/18 - 11:12 pm
CAR-T
bispecific antibodies
BIO 2018
ASCO 2018
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Endpoints
Mon, 02/12/18 - 09:49 am
Roche
bispecific antibodies
RG7716
Novartis
Eylea
J&J antes $50M to get Zymeworks’ 6th big bispecifics alliance underway, with $6B in total milestones on the table
Endpoints
Mon, 11/13/17 - 09:16 am
JNJ
Zymeworks
drug development
bispecific antibodies
Amgen, Immatics In Cancer Drug Partnership
Investopedia
Mon, 01/9/17 - 10:10 am
Amgen
Immatics
bispecific antibodies
R&D
cancer
Incyte puts up $200M in bispecifics deal with Merus
BioPharma Dive
Thu, 12/22/16 - 10:21 am
Incyte
Merus
bispecific antibodies
AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
Endpoints
Tue, 11/29/16 - 09:51 am
AstraZeneca
bispecific antibodies
MedImmune
AbPro
cancer
Novartis jumps into bi-specific antibody space with $150 million Xencor deal
BioPharma Dive
Tue, 06/28/16 - 11:14 am
Novartis
bispecific antibodies
Xencor
acute myeloid leukemia
B-cell malignancies
GSK doubles down on Zymeworks’ platform technologies with $908M deal
Fierce Biotech
Wed, 04/27/16 - 09:23 am
GSK
Zymeworks
R&D
bispecific antibodies
drug development
Novimmune and Baxalta ink international bispecific antibody collaboration
Yahoo
Wed, 09/2/15 - 10:24 am
Novimmune
Baxalta
R&D
bispecific antibodies
Micromet Leads in Bispecific Antibodies
Seeking Alpha
Wed, 05/11/11 - 12:32 pm
Micromet
bispecific antibodies
Pages
« first
‹ previous
1
2
3
4